XML 39 R2.htm IDEA: XBRL DOCUMENT v3.24.4
Pay vs Performance Disclosure
number in Millions
 12 Months Ended
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Pay vs Performance Disclosure        
Pay vs Performance Disclosure, Table
Value of Initial Fixed $100
Investment Based On:
Year (1)
(a)
Summary Compensation Table Total for CEO
(b)
Compensation Actually Paid to CEO (2)
(c)
Average Summary Compensation Table Total for Non-CEO NEOs
(d)
Average Compensation Actually Paid to Non-CEO NEOs (3)
(e)
Total Shareholder Return
(f)
Peer Group Total Shareholder Return(4)
(g)
Net Income
(in millions)
(h)
Revenue (in millions)(5)
(i)
2024$7,620,611 $24,977,300 $2,683,449 $6,359,699 $59.47 $115.57 $(280.7)$313.0 
2023$7,998,637 $3,219,824 $3,086,321 $1,648,641 $26.67 $95.05 $(204.6)$245.1 
2022$5,917,663 $(15,039,602)$2,484,123 $(3,534,350)$46.39 $89.85 $(217.9)$203.6 
2021$1,281,593 $18,054,219 $728,146 $6,408,876 $140.81 $120.21 $(152.1)$132.3 
__________________
      
Company Selected Measure Name revenue      
Named Executive Officers, Footnote The CEO and other NEOs for the indicated years were as follows: (i) for 2024, our CEO was Dr. Leproust and our other NEOs were Mr. Laponis, Dr. Finn, Ms. Green, Mr. Cho, Dr. Banyai, and Mr. Thorburn; (ii) for 2023, our CEO was Dr. Leproust and our other NEOs were Mr. Thorburn, Dr. Banyai, Dr. Finn, and Ms. Green; (iii) for 2022, our CEO was Dr. Leproust and our other NEOs were Mr. Thorburn, Dr. Banyai, Dr. Finn, Mr. Cho, and Mr. Weiss; and (iv) for 2021, our CEO was Dr. Leproust and our other NEOs were Mr. Thorburn, Dr. Banyai, Dr. Finn, and Mr. Weiss.      
Peer Group Issuers, Footnote For each indicated covered year, represents the cumulative TSR of the Nasdaq Biotechnology Index.(5)In      
PEO Total Compensation Amount $ 7,620,611 $ 7,998,637 $ 5,917,663 $ 1,281,593
PEO Actually Paid Compensation Amount $ 24,977,300 3,219,824 (15,039,602) 18,054,219
Adjustment To PEO Compensation, Footnote Amounts reported in this column are based on total compensation reported for our CEO in the Summary Compensation Table for the indicated fiscal years and adjusted as shown in the tables below. Fair value of equity awards was computed in accordance with the Company’s methodology used for financial reporting purposes.
Fiscal Year
Summary Compensation Table
Total
Adjustment to Summary Compensation Table
Total(1)
Compensation Actually Paid
2024$7,620,611 $17,356,689 $24,977,300 
2023$7,998,637 $(4,778,813)$3,219,824 
2022$5,917,663 $(20,957,265)$(15,039,602)
2021$1,281,593 $16,772,626 $18,054,219 
__________________
(1) See table below for calculation of Adjustment to Summary Compensation Table Total

Fiscal Year Deduction of Grant Date Fair Value of Current year Equity AwardsAddition of Fair Value of Current Year Equity Awards at Fiscal Year EndAdditions (Deductions) for Change in Value of Prior Years’ Awards Unvested at Fiscal Year End Additions (Deductions) for Awards that are Granted and Vest in the Same Covered Fiscal Year Additions (Deductions) for Change in Value of Prior Years’ that Vested in Fiscal Year Adjustment to Summary Compensation Table Total
2024$(5,849,949)$13,837,233 $7,705,047 $1,178,291 $486,067 $17,356,689 
2023$(6,632,151)$4,259,928 $(1,518,003)$208,413 $(1,097,000)$(4,778,813)
2022$(4,521,127)$2,416,154 $(11,693,150)$138,996 $(7,298,138)$(20,957,265)
2021$— $— $9,403,372 $— $7,369,254 $16,772,626 
      
Non-PEO NEO Average Total Compensation Amount $ 2,683,449 3,086,321 2,484,123 728,146
Non-PEO NEO Average Compensation Actually Paid Amount $ 6,359,699 1,648,641 (3,534,350) 6,408,876
Adjustment to Non-PEO NEO Compensation Footnote Amounts reported in this column are based on the average of the total compensation reported for our other NEOs in the Summary Compensation Table for the indicated fiscal years and adjusted as shown in the tables below. Fair value of equity awards was computed in accordance with the Company’s methodology used for financial reporting purposes.
Fiscal Year
Average Summary Compensation Table
Total
Adjustment to Average Summary Compensation Table
Total(1)
Average Compensation Actually Paid
2024$2,683,449$3,676,250$6,359,699
2023$3,086,321$(1,437,680)$1,648,641
2022$2,484,123$(6,018,473)$(3,534,350)
2021$728,146$5,680,730$6,408,876
__________________
(1) See table below for calculation of Adjustment to Average Summary Compensation Table Total

Fiscal Year
Deduction of Grant Date Fair Value of Current Year
Addition of Fair Value of Current Year Equity Awards at Fiscal Year EndAdditions (Deductions) for Change in Value of Prior Years’ Awards Unvested at Fiscal Year End Additions (Deductions) for Awards that are Granted and Vest in the Same Covered Fiscal Year Additions (Deductions) for Change in Value of Prior Years’ that Vested in Fiscal Year
Adjustment to Average Summary Compensation Table Total
2024$(1,855,631)$3,422,378 $1,713,610 $254,130 $141,763 $3,676,250 
2023$(2,319,610)$1,220,625 $(554,184)$97,636 $117,853 $(1,437,680)
2022$(1,795,865)$975,053 $(3,248,755)$49,024 $(1,997,930)$(6,018,473)
2021$— $— $3,217,733 $— $2,462,997 $5,680,730 
      
Tabular List, Table Revenue
•Adjusted Gross Profit
•Ending Cash Balance 		     
Total Shareholder Return Amount $ 59.47 26.67 46.39 140.81
Peer Group Total Shareholder Return Amount 115.57 95.05 89.85 120.21
Net Income (Loss) $ (280,700,000) $ (204,600,000) $ (217,900,000) $ (152,100,000)
Company Selected Measure Amount 313.0 245.1 203.6 132.3
PEO Name Dr. Leproust      
Additional 402(v) Disclosure In accordance with SEC rules, the Company is required to include in the Pay versus Performance table the “most important” financial performance measure (as determined by the Company) used to link compensation actually paid to our NEOs to Company performance for the most recently completed fiscal year. The Company determined revenue, which is a metric included in our incentive program, meets this requirement and therefore, we have included this performance measure in the Pay versus Performance table.      
Measure:: 1        
Pay vs Performance Disclosure        
Name Revenue      
Measure:: 2        
Pay vs Performance Disclosure        
Name Adjusted Gross Profit      
Measure:: 3        
Pay vs Performance Disclosure        
Name Ending Cash Balance      
PEO        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount $ 17,356,689 $ (4,778,813) $ (20,957,265) $ 16,772,626
PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 13,837,233 4,259,928 2,416,154 0
PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 7,705,047 (1,518,003) (11,693,150) 9,403,372
PEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 1,178,291 208,413 138,996 0
PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 486,067 (1,097,000) (7,298,138) 7,369,254
PEO | Deduction of Grant Date Fair Value of Current Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (5,849,949) (6,632,151) (4,521,127) 0
Non-PEO NEO        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 3,676,250 (1,437,680) (6,018,473) 5,680,730
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 3,422,378 1,220,625 975,053 0
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 1,713,610 (554,184) (3,248,755) 3,217,733
Non-PEO NEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 254,130 97,636 49,024 0
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 141,763 117,853 (1,997,930) 2,462,997
Non-PEO NEO | Deduction of Grant Date Fair Value of Current Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount $ (1,855,631) $ (2,319,610) $ (1,795,865) $ 0